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The ongoing molecular investigation of the basic contractile
units of the sarcomere in striated muscles have revealed a
highly complex system composed of a large number
of proteins each one with a specific task.1 However, a
growing number of studies is pointing the attention to the
fact that many of these structural proteins may also be
involved in pathways and functions other than contraction
but always related to muscle cell maintenance, repair,
differentiation, signaling, etc.1 In this context an important
role has been attributed to the muscle LIM protein (MLP).
MLP is a member of the cysteine and glycine rich protein
(CSRP) family that is composed by CSRP1, CSRP2 and
CSRP3 or MLP. CSPRs, in turn, belong to the larger family of
LIM domain proteins.2 MLP is expressed in striated muscle
at the level of sarcomere, the intercalated disk and the
costamere where it interacts with telethonin, α-actinin,
cofilin-2 and calcineurin among others and contains two
LIM domains that are zinc finger domains composed of ~ 55
aminoacids with 8 highly conserved residues, mostly
cysteine and histidine that are located at defined
intervals.2 Through the LIM domain, MLP can modulate
protein interaction and formation of macromolecular struc-
tures. Another peculiarity of MLP is that it can shuttle from
the cytosol to the nucleus where it serves as a scaffold
protein to adapt transcription factors to their DNA-binding
sequences.2,3 In fact, MLP is involved myocyte differentia-
tion by activating transcription factors such as MyoD,
myogenin, etc.4 To this effect, mutations in the N-terminal
region of MLP have been linked to the development of dilated
cardiomyopathy (DCM) or hypertrophic cardiomyopathy
(HCM). Moreover, MLP protein levels or intracellular
localization are altered in skeletal myopathies, such
as fascioscapulohumeral muscular dystrophy, nemaline
myopathy and limb girdle muscular dystrophy type 2B.5,6
Therefore, the current dogma foresee an important role for
MLPin the maintenance of muscle cytoarchitecture as well
as in the differentiation of muscle cells. However, the cellular
and molecular mechanism(s) through which MLP carries out
its function is (are) still obscure.
Using a myoblast cell line we have recently demonstrated
that MLP uses macroautophagy to control differentiation
of myobalsts into myotubes as well as survival of
myotubes in the presence of a cell death stimulus.7
In particular, we have used MLP silenced myoblasts to
show an impairment of autophagy that, in turn, results in
decreasedmyotubes formation and decreased resistance to
cell death. However, the question was: how can MLP control
autophagy? We provided evidences that MLP interacts
and associates with LC3, a widely used autophagy marker
with a crucial role during autophagosome formation. Inter-
estingly both MLP and LC3 are microtubule associated
proteins. Therefore, besides controlling muscle cell differ-
entiation by modulating the expression of MyoD1 and
myogenin mRNA, we also show that cytosolic MLP is
important for the correct assembly and flux of the autophagic
machinery. In fact, MLP silencing not only decreased LC3-II
accumulation but also resulted in impaired degradation of
long-lived proteins. Interestingly, morphological analysis of
myotubes lacking MLP expression by transmission electron
microscopy revealed the accumulation of damaged mito-
chondria and multi-membranous structures.Of note, the
same multi-membranous structures with sarcomere disor-
ganization have been described in skeletal muscles from
Atg7–/– and Atg5–/– mice through the accumulation of
damaged organelles and material. The final phenotype
of these mice is characterized by muscle atrophy and
features of myopathy.8 In fact, increasing evidences
suggest that autophagy has an important physiological role
during development, differentiation and muscle mass
maintenance.9
Autophagy has also been linked to another physiological
pathway such as apoptosis. Like autophagy, apoptosis has a
fundamental role during development and differentiation. In
fact, autophagy and apoptosis uses common proteins and it
is widely accepted that increased autophagy represent a
protective mechanism from apoptotic cell death. Such
knowledge derives from oncology in which cancer cells
increases resistance to chemotherapy-induced apoptosis by
increasing autophagic flux and removal of damaged orga-
nelles and proteins.10 Our results show that reduced MLP
expression with reduced autophagy, increases sensitivity of
myotubes to apoptogens and cell death. This suggests that
autophagy may represent a mechanism through which
muscle cells can recover from a stress or a sub-lethal
damage that do not kill the cell but requires extensive
remodeling of internal structures.
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Our results shed new light on the MLPand on its central role
for muscle cell differentiation and remodeling. As shown in
Figure 1, in skeletal muscle cells, MLP can be activated by
exogenous signals such as mechanical, toxic, growth factors,
etc. Once activated, MLP can move to the nucleus and/or
remain in the cytosol where associates with LC3 to control the
autophagic process. In this way, as nuclear MLP binds to
myogenic transcription factor, thereby activating de novo
synthesis of structural genes, cytosolic MLP regulates
autophagy thereby controlling recycling of organelles and
proteins and providing building blocks for muscle cell
cytoarchitectural remodeling.
In conclusion, even if mutations in MLP have been linked
to DCM and HCM and deregulation of MLP to skeletal
muscle diseases, new questions arise. For example:
which are the pathogenic mechanisms activated by
the lack or inactivation of MLP? Can MLP be used as a
therapeutic target? The identification of the mechanism(s)
of action of MLP may drive the development of new
strategies for increasing skeletal muscle cell survival and
remodeling.
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Figure 1 Multitasking properties of MLP. Exogenous stimuli activate MLP that, from one side, translocates to the nucleus where it binds to myogenic transcription factors and,
from the other side, controls autophagy and recycling of damaged or disfunctional organelles and proteins. Both nuclear and cytosolic functions of MLP converge to differentiation
and survival in myoblasts (a) and to remodeling in myocytes (b)
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